CCP
IMPV

Clough Capital Partners’s Imperva, Inc. IMPV Stock Holding History

Clough Capital Partners’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-69,840
Closed -$2.94M – 238
2013
Q3 		$2.94M Buy
+69,840
New +$3.33M 0.09% 161

Other funds holding IMPV

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Clough Capital Partners's IMPV Position: Q4 2013 in Review

Clough Capital Partners sold out of Imperva, Inc. (IMPV) in Q4 2013, closing a stake of 69,840 shares — an estimated $2.94M sold.

Clough Capital Partners first reported a position in IMPV in Q3 2013 and held it in 1 quarter. The position peaked at $2.94M in Q3 2013. 127 funds tracked by Wall St. Rank hold IMPV as of Q4 2013.

  • Clough Capital Partners reported no remaining Imperva, Inc. position as of Q4 2013 after selling out during the quarter.
  • Clough Capital Partners sold 69,840 Imperva, Inc. shares in Q4 2013, an estimated $2.94M.
  • Clough Capital Partners first reported a position in Imperva, Inc. in Q3 2013 and held it in 1 quarter.
  • Clough Capital Partners's Imperva, Inc. position peaked at $2.94M in Q3 2013.
  • 127 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2013.

Based on Clough Capital Partners's 13F filing for Q4 2013, filed 14 Feb 2014.